This application proposes novel investigations of the natural history of injection drug use, from initiation to cessation or death, as well as studies of trends in morbidity and mortality. We propose to undertake this work in Vancouver, Canada, where the steady growth in prescription opiate (PO) misuse has become a growing concern. Accordingly, we also seek to evaluate the impact of PO misuse on the natural history of injection drug use in an environment with an active heroin market, including the impact of PO use on injecting initiation and cessation, HIV risk behavior and overdose. We also aim to characterize early injecting careers and to identify the individual, social-structural and environmental factors that shape injecting initiation, early cessation of injecting, sustained injecting, and HIV risk behavior. Focusing on established injectors, we further aim to describe the individual, social-structural and environmental factors that shape cessation of and relapse into injecting, and associated morbidity and mortality. Our project involves the creation of a unique cohort, the Vancouver Drug Users Study (V-DUS, n = 1800), which involves adults who inject drugs and non-injecting street-involved drug-using youth. Participants provide behavioral information and biological specimens for testing, repository, and use by our team and other NIDA investigators. Members of our multidisciplinary team have more than two decades of experience conducting NIDA-funded cohort-based research, most recently through studies of IDU participating in the Vancouver Injection Drug Users Study (VIDUS), which is one of the longest-standing IDU cohort studies in the world, and street-involved drug-using youth participating in the At- Risk Youth Study (ARYS). In order to take advantage of considerable efficiencies, both academic and financial, we propose merging the ARYS and VIDUS cohorts into the Vancouver Drug Users Study (V-DUS), enabling a critical additional five years of investigation into the natural history f injection drug use. Vancouver is ideally suited for the proposed study for several reasons. The city was home to one of the most explosive HIV epidemics ever documented among IDU, and Vancouver is a port of entry for illicit drugs and is now experiencing a PO misuse epidemic. Further, under the province of British Columbia's universal healthcare plan, we are able to link cohort data to various administrative databases, permitting assessments of barriers to care that are free of the confounding effects of medical insurance schemes, and our established multidisciplinary team and other NIDA investigators use our cohort platform to undertake diverse work in the areas of clinical epidemiology, social, spatial, and basic science, as well as modeling and cost-effectiveness studies. Lastly, Vancouver has been the site of the development of a range of innovative programs for IDU and therefore we plan to use this cohort infrastructure to build on our track record of evaluating highly innovative programs for IDU, as well as other naturally occurring events. Through this work, we aim to address several urgent global health challenges and inform the development of policies and interventions that seek to address illicit drug use.

Public Health Relevance

The purpose of this proposed cohort study is to examine the natural history of injection drug use, from initiation to cessation or death, as well as trends in morbidity and mortality. This study will involve 1800 participants in Vancouver, Canada, including HIV- negative injection drug users and high-risk non-injection drug-using youth.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01DA038886-02
Application #
9002025
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Lambert, Elizabeth
Project Start
2015-03-01
Project End
2019-11-30
Budget Start
2015-12-01
Budget End
2016-11-30
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of British Columbia
Department
Type
DUNS #
251949962
City
Vancouver
State
BC
Country
Canada
Zip Code
V6 1Z3
Reddon, Hudson; Pettes, Tyler; Wood, Evan et al. (2018) Incidence and predictors of mental health disorder diagnoses among people who inject drugs in a Canadian setting. Drug Alcohol Rev 37 Suppl 1:S285-S293
Walton, Geoffrey; Dong, Huiru; Milloy, M J et al. (2018) Increasing availability of benzodiazepines among people who inject drugs in a Canadian setting. Subst Abus 39:69-76
Barker, Brittany; Hadland, Scott E; Dong, Huiru et al. (2018) Increased burden of suicidality among young street-involved sex workers who use drugs in Vancouver, Canada. J Public Health (Oxf) :
Jaffe, Kaitlyn; Dong, Huiru; Godefroy, Anna et al. (2018) Informal recycling, income generation and risk: Health and social harms among people who use drugs. Int J Drug Policy 60:40-46
Randhawa, Gurdeeshpal; Azarbar, Ataa; Dong, Huiru et al. (2018) Childhood Trauma and the Inability to Access Hospital Care Among People who Inject Drugs. J Trauma Stress 31:383-390
Klimas, Jan; Dong, Huiru; Fairbairn, Nadia et al. (2018) Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting. Addict Sci Clin Pract 13:3
Hayashi, Kanna; Milloy, M-J; Lysyshyn, Mark et al. (2018) Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study. Drug Alcohol Depend 183:1-6
Jacka, B; Bray, B C; Applegate, T L et al. (2018) Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach. J Viral Hepat 25:28-36
Young, Samantha; Wood, Evan; Milloy, M-J et al. (2018) Hepatitis C cascade of care among people who inject drugs in Vancouver, Canada. Subst Abus :1-8
SocĂ­as, Maria Eugenia; Wood, Evan; Lake, Stephanie et al. (2018) High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis. Addiction 113:2250-2258

Showing the most recent 10 out of 146 publications